Keynote comment: nitrosatable drugs, cancer, and guidelines for genotoxicity

被引:3
作者
Brambilla, G [1 ]
Martelli, A [1 ]
机构
[1] Univ Genoa, Dept Internal Med, Clin Pharmacol & Toxicol Unit, I-16126 Genoa, Italy
关键词
D O I
10.1016/S1470-2045(05)70257-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:538 / 539
页数:2
相关论文
共 5 条
[1]  
BRAMBILLA G, 1985, J TOXICOL ENV HEALTH, V15, P1
[2]  
*INT AG RES CANC, 1987, IARC MON EV CARC S7, V1, P37
[3]  
International Agency for Research on Cancer, 1980, IARC MON EV CARC RIS, V24, P297
[4]   ICH-harmonised guidances on genotoxicity testing of pharmaceuticals:: evolution, reasoning and impact [J].
Müller, L ;
Kikuchi, Y ;
Probst, G ;
Schechtman, L ;
Shimada, H ;
Sofuni, T ;
Tweats, D .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1999, 436 (03) :195-225
[5]  
OHSHIMA H, 1981, CANCER RES, V41, P3658